From: Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/RT: Evidence for synergy with Topoisomerase-I inhibition
Inhibitor, CI
BT 12
BT 16
KCCF1
Sorafenib
0.7
0.8
0.9
Sunitinib
0.3
0.4